Severe central nervous system thrombotic events in hemoglobin Sabine patient

被引:10
作者
Pavlovic, S
Kuzmanovic, M
Urosevic, J
Poznanic, J
Zoranovic, T
Djordjevic, V
Rasovic, N
Bunjevacki, G
Cvorkov-Drazic, M
Colovic, M
机构
[1] Inst Mol Genet & Genet Engn, YU-11000 Belgrade, Serbia Monteneg, Serbia
[2] Mother & Child Hlth Inst Serbia Dr Vukan Cupic, Belgrade, Serbia Monteneg, Serbia
[3] Clin Ctr Serbia, Belgrade, Serbia Monteneg, Serbia
关键词
Hb Sabine; genetic predisposition to thrombophilia; cerebrovascular insults;
D O I
10.1046/j.0902-4441.2004.00174.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemoglobin (Hb) Sabine is a rare, unstable Hb variant resulting from the point mutation in codon 91 (CTG --> CCG) of beta-globin gene. We report a case of Hb Sabine patient with mild hemolytic anemia, unusually high Hb F level and severe central nervous system thrombotic disturbances. We have tried to elucidate possible genetic background of this unusual Hb Sabine phenotype. Extremely high level of Hb F and rather mild anemia in our patient could be partially explained by the presence of Ggamma Xmn I polymorphism. This case of Hb Sabine, unlike all other reported to date, shows extremely severe thromboembolic complications. It is our opinion that the hypercoagulable state described in thalassemia is not the only factor responsible for this specific clinical state. The presence of MTHFR C677T mutation in heterozygous state found in our patient and unstable Hb Sabine molecules could contribute to development of thromboembolic phenomena. However, it remains unclear whether other factors participate in pathogenesis of the disease. In this paper we emphasize different genetic background of father and son both affected with Hb Sabine, but with markedly different severity of the disease.
引用
收藏
页码:67 / 70
页数:4
相关论文
共 20 条
[1]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[2]  
BOGOEVSKI P, 1983, HEMOGLOBIN, V7, P195
[3]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[4]   Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia [J].
Cappellini, MD ;
Robbiolo, L ;
Bottasso, BM ;
Coppola, R ;
Fiorelli, G ;
Mannucci, PM .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (02) :467-473
[5]   The hypercoagulable state in thalassemia [J].
Eldor, A ;
Rachmilewitz, EA .
BLOOD, 2002, 99 (01) :36-43
[6]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[7]  
GASPERINI D, 1992, HAEMATOLOGICA, V77, P381
[8]   C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations [J].
Gudnason, V ;
Stansbie, D ;
Scott, J ;
Bowron, A ;
Nicaud, V ;
Humphries, S .
ATHEROSCLEROSIS, 1998, 136 (02) :347-354
[9]   Familial hemolytic anemia due to Hb sabine [β91(F7)Leu→Pro] identified by polymerase chain reaction [J].
Hull, D ;
Winter, PC ;
McHale, CM ;
Lappin, TRJ ;
Mayne, EE .
HEMOGLOBIN, 1998, 22 (03) :263-266
[10]   Venous thromboembolism, factor V Leiden, and methylenetetrahydrofolate reductase in a sickle cell anemia patient [J].
Koren, A ;
Zalman, L ;
Levin, C ;
Abu Hana, M ;
Mader, R ;
Shalev, S .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1999, 16 (05) :469-472